The Modern U.S. Vaccine Causes Increased Risk of Heart Inflammation – Washington Post

August 19 (Reuters) – US health officials are investigating reports that Moderna Inc.’s COVID-19 vaccine (MRNA.O) may be linked to a higher risk of heart disease in younger adults than he thought, the Washington Post reported Thursday afternoon, citing people familiar with the review.

The report cited a source who said it was too early for regulators to reach a conclusion and that more work needed to be done before making any recommendations.

In June, health regulators had added a warning to the literature accompanying the mRNA vaccines produced by Moderna and Pfizer to mark the rare risk of heart inflammation seen primarily in young men. However, they said the benefit of the shots to prevent COVID-19 continued to outweigh the risks. Read more

There may be a 2.5-fold higher incidence of myocarditis in those receiving the Modern vaccine compared to the Pfizer vaccine, a source said.

Research focused on Canadian data suggests that the risks of myocarditis could be especially higher in men under the age of about 30, according to the report.

Moderna and the U.S. Food and Drug Administration (FDA) did not immediately respond to requests for Reuters comments.

Report by Shubham Kalia in Bengaluru; Edited by Krishna Chandra Eluri and Ramakrishnan M.

Our standards: the principles of trust of Thomson Reuters.